Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life

Radiotherapy and Oncology

Volumn 96, Issue 1, 2010, Pages 38-42

  Moman, Maaike R ^a   van der Heide, Uulke A ^a   Kotte, Alexis N T J ^a   van Moorselaar, R Jeroen A ^b   Bol, Gijsbert H ^a   Franken, Stefan P G ^a   van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fiducial markers; Position verification; Prostate cancer; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CHILL; EXTERNAL BEAM RADIOTHERAPY; FEVER; HEMATURIA; HEMOSPERMIA; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTHESIS FAILURE; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM DISEASE; RETROSPECTIVE STUDY; UROSEPSIS; VISUAL ANALOG SCALE;

AGED; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; GOLD RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERINEUM; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77953963382     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.027     Document Type: Article

References (21)

1. van der Heide U.A., Kotte A.N., Dehnad H., Hofman P., Lagenijk J.J., and van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
2. McNair H.A., Hansen V.N., Parker C.C., et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71 (2008) 41-50
3. van der Vight L.P., van Lin E.N., Spitters-Post I., Visser A.G., and Louwe R.J. Off-line setup corrections only marginally reduce the number of on-line corrections for prostate radiotherapy using implanted gold markers. Radiother Oncol 90 (2009) 359-366
4. Kotte A.N., Hofman P., Lagendijk J.J., van Vulpen M., and van der Heide U.A. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69 (2007) 419-425
5. Lips I., Dehnad H., Kruger A.B., van Moorselaar J., et al. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys 69 (2007) 656-661
6. Lips I.M., Dehnad H., van Gils C.H., Boeken Kruger A.E., van der Heide U.A., and van Vulpen M. High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol 3 (2008) 15
7. Al Mamgani A., van Putten W.L., Heemsbergen W.D., van Leenders G.J., Slot A., Dielwart M.F., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
8. Poggi M.M., Gant D.A., Sewchand W., and Warlick W.B. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 56 (2003) 1248-1251
9. Nichol A.M., Brock K.K., Lockwood G.A., et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 67 (2007) 48-56
10. Dehnad H., Nederveen A.J., van der Heide U.A., van Moorselaar R.J., Hofman P., and Lagendijk J.J. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
11. Hornbrook M.C., and Goodman M.J. Assessing relative health plan risk with the RAND-36 health survey. Inquiry 32 (1995) 56-74
12. Aaronson N.K., Muller M., Cohen P.D., Essink-Bot M.L., Fekkes M., Sanderman R., et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51 (1998) 1055-1068
13. Borghede G., and Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 5 (1996) 212-222
14. van Andel G., Bottomley A., Fossa S.D., et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 44 (2008) 2418-2424
15. Langenhuijsen J.F., van Lin E.N., Kiemeney L.A., et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys 69 (2007) 671-676
16. Osoba D., Bezjak A., Brundage M., Zee B., Tu D., and Pater J. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 41 (2005) 280-287
17. Henry A.M., Wilkinson C., Wylie J.P., Logue J.P., Price P., and Khoo V.S. Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol 73 (2004) 57-59
18. Hara R., Jo Y., Fujii T., et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 71 (2008) 191-195
19. Nederveen A.J., Dehnad H., van der Heide U.A., van Moorselaar R.J., Hofman P., and Lagendijk J.J. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 68 (2003) 81-88
20. Kitamura K., Shirato H., Shimizu S., et al. Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother Oncol 62 (2002) 275-281
21. Pouliot J., Aubin M., Langen K.M., et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys 56 (2003) 862-866